Medication info

Anesin Cream

Prescription medicationCream
Ingredient · strength
Lidocaine›25mg / 1gPrilocaine›25mg / 1g
Manufacturer / importer
Simic CMO Korea Co., Ltd.
Appearance
White cream
Packaging
10g/tube, 500g/container
Approval status
Active

MFDS item code 200503285 · Notified 2005.04.20

Summary

Main use
Pain relief through topical anesthesia of the skin, genital mucosa, and leg ulcers
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Skin: After applying this medicine, cover the area with an occlusive dressing. The application site should generally remain covered for 1-3 hours, and the effect persists for at least 1 hour after the dressing is removed. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply approximately 2g of this medicine for at least 1 hour and up to 5 hours. 2) For minor superficial surgery (e.g., removal of molluscum contagiosum), apply 1.5 -2g/10㎠ for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10㎠ for at least 2 hours and up to 5 hours. 2. Genital mucosa: For removal of condylomata, apply approximately 10g of this medicine to the treatment site for 5-10 minutes, then remove the medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use each opened tube only once and discard any cream remaining after each procedure. Apply 1-2g/10cm<sup>2</sup> for at least 30 minutes, without exceeding 10g per treatment. For leg ulcers with tissue that is difficult to debride, the application time may be extended to 60 minutes; cleanse the ulcer within 10 minutes after removing the cream. No decrease in efficacy or increase in local reactions was observed with use up to 15 times over 1-2 months.
Children's dosage
Infants aged 3 months-12 months: Do not exceed a total amount of 2g or an application area of 16㎠.

Ingredients

Manufacturer
Simic CMO Korea Co., Ltd.

Efficacy & effects

Pain relief through topical anesthesia of the skin, genital mucosa, and leg ulcers

  • Surface anesthesia of the skin
  • surface anesthesia of the genital mucosa
  • surface anesthesia of leg ulcers
View approved original text

This medication is used to anesthetize the skin surface when inserting a needle or performing superficial surgical procedures. It also provides anesthesia when applied to the genital mucosa, such as before condyloma removal procedures. Additionally, it is used for surface anesthesia of leg ulcers, numbing the areas required during washing or superficial surgery to reduce pain. Overall, it is effective for surface anesthesia of the skin or mucosa.

Dosage and Administration

Adult dosage

○ Adults 1. Skin: After applying this medicine, cover the area with an occlusive dressing. The application site should generally remain covered for 1-3 hours, and the effect persists for at least 1 hour after the dressing is removed. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply approximately 2g of this medicine for at least 1 hour and up to 5 hours. 2) For minor superficial surgery (e.g., removal of molluscum contagiosum), apply 1.5 -2g/10㎠ for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10㎠ for at least 2 hours and up to 5 hours. 2. Genital mucosa: For removal of condylomata, apply approximately 10g of this medicine to the treatment site for 5-10 minutes, then remove the medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use each opened tube only once and discard any cream remaining after each procedure. Apply 1-2g/10cm<sup>2</sup> for at least 30 minutes, without exceeding 10g per treatment. For leg ulcers with tissue that is difficult to debride, the application time may be extended to 60 minutes; cleanse the ulcer within 10 minutes after removing the cream. No decrease in efficacy or increase in local reactions was observed with use up to 15 times over 1-2 months.

Children's dosage

Infants aged 3 months-12 months: Do not exceed a total amount of 2g or an application area of 16㎠.

Precautions

This medication is used as a local anesthetic and may cause a rare blood disorder known as methemoglobinemia. This condition can lead to a decrease in the oxygen-carrying capacity of the blood, resulting in a bluish discoloration of the skin. Caution is especially needed in patients with glucose-6-phosphate dehydrogenase deficiency, congenital methemoglobinemia, heart or lung impairment, infants less than 6 months old, or when used with oxidizing agents, as symptoms may be more severe. This medication should not be used in patients with hypersensitivity to any components, or in those with wounds, mucosal sites, contact dermatitis, or atopic dermatitis, infants under 3 months of age, and those under 12 months who are receiving medications that induce methemoglobinemia, as well as premature infants born before 37 weeks. Caution should be exercised in those with a history of anemia or methemoglobinemia, as well as in the frail, elderly, and those with liver disease, and those with an allergy to propylene glycol contained in this medication. Local reactions, such as pallor, redness, swelling, itching, and initial burning sensations, may occur upon use, and rarely severe allergic reactions such as urticaria, angioedema, bronchospasm, and shock may develop. Special attention should be given to children, as methemoglobinemia can occur rarely. This medication is generally safe when used at the recommended doses; however, it may affect the central nervous system or the heart in some patients, necessitating immediate medical treatment if symptoms occur. Additionally, it is preferable not to use this medication in conjunction with live vaccines. It should not be applied around the eyes, middle ear, or open wound sites, and if contact with the eyes occurs, they should be rinsed immediately and protected. Women who are pregnant or breastfeeding should also use this medication cautiously, and it should only be used with limitations in children, especially infants under 3 months. In cases of overdose, severe neurological symptoms or methemoglobinemia may occur, requiring immediate medical intervention, with methylthioninium potentially used as an antidote. Lastly, long-term high-dose use of this medication raises concerns about potential accumulation of metabolites that could be carcinogenic, so long-term use should be avoided.

Side effects

  • Localized pallor
  • erythema
  • edema
  • itching
  • initial burning sensation
  • urticaria
  • angioedema
  • bronchospasm
  • shock
  • methemoglobinemia
Show 3 more
  • purpura
  • petechiae
  • corneal irritation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, to maintain the effectiveness of the drug, it is important to store it at room temperature, between 1 degree and 30 degrees.

Appearance and packaging

Appearance

White cream

Package unit

10g/tube, 500g/container

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.